Showing results (91-100 of 140) with videos related to
Sort By:
Pageof 14
Clinical Lung Cancer|April 19, 2017
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung CancerShinjiro Sakamoto, Teppei Yamada, Yasuhiro Terazaki, et al.International Journal of Clinical Oncology|April 5, 2024
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitorsHirotaka Nagasaka, Takeshi Kishida, Taku Kouro, et al.Journal of Immunology Research|June 9, 2016
Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung CancerKoichi Takayama, Shunichi Sugawara, Yasuo Saijo, et al.Cancer Immunology, Immunotherapy : CII|May 15, 2023
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitorsHidetomo Himuro, Yoshiro Nakahara, Yuka Igarashi, et al.Frontiers in Immunology|June 1, 2026
Gut microbiome functional pathways outperform taxonomic profiles in predicting immune checkpoint inhibitor response in non-small cell lung cancer: an interpretable machine learning approach with SHAPFeifei Wei, Yoshiro Nakahara, Junya Isobe, et al.Cancer Science|February 11, 2012
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancerYasuhiro Terazaki, Koichi Yoshiyama, Satoko Matsueda, et al.Cancer Immunology, Immunotherapy : CII|May 20, 2020
Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinomaRyosuke Jikuya, Takeshi Kishida, Masahiko Sakaguchi, et al.Plos One|November 14, 2013
EGFR T790M mutation as a possible target for immunotherapy; identification of HLA-A*0201-restricted T cell epitopes derived from the EGFR T790M mutationTeppei Yamada, Koichi Azuma, Emi Muta, et al.Cancer Science|July 28, 2015
Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 alleleShinjiro Sakamoto, Satoko Matsueda, Shinzo Takamori, et al.International Journal of Cancer|January 12, 2024
Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1Taku Kouro, Naoko Higashijima, Shun Horaguchi, et al.Pageof 14